Lazard Inc (LAZ)
NYSEFinancialsFinancial - Capital MarketsSnapshot 2026-10-29
$38.35-3.01%
Close 2026-10-30 · 1-day change
NYSEFinancialsFinancial - Capital MarketsSnapshot 2026-10-29
Research Workspace
Put LAZ beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Investment Banking & Brokerage is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Improve cash from operating activities toward positive levels: Comparison needs review.
View ThesisRevenue is growing steadily — about 9% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, margins, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 39% in its worst 12-month stretch.
View RiskLazard’s bet rests on growing its asset management business and assets under management. Revenue growth rose from 1% to 9%, yet third-quarter earnings missed estimates. The shares trade at 23 times earnings versus 17 times for peers. That premium conflicts with expectations that look modest against our growth view. A 45% modelled next-quarter miss risk threatens the case. Reported profits are weakly backed by cash. The operating-cash pillar is under pressure, but its comparison needs review. Peer multiples imply a price about 21% below where it trades. This read is provisional.
Trailing returns as of 2026-10-30. LAZ is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 10 analysts currently covering LAZ (as of Oct 2026).
Based on 4 Wall Street analysts offering 12-month price targets for LAZ in the last 4 months.
Continue this research
Compare LAZ with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| LAZ Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Investment Banking & Brokerage — fair value, gap to price, and forward P/E.
Compare the value case
Put LAZ next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Complete strategic acquisitions
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $38.35
The last 12 months of price, then the range of analyst 12-month targets from today’s $38.35.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Planned Campbell Lutyens integration and projected revenue advance acquisition strategy and growth.
Threatens: Advance Lazard 2030 growth strategy and repositioning
Q3 revenue and EPS miss, tied to deal pull-forwards, expose advisory volatility.
Threatens: Advance Lazard 2030 growth strategy and repositioning
Q3 revenue and earnings miss estimates, weakening near-term advisory performance.
Involvement in debt talks may lead to strategic acquisition.
Strategic partnership aligns with growth objectives.
Threatens: Complete strategic acquisitions
M&A weakness impacts growth strategy and overall thesis.
Threatens: Complete strategic acquisitions
Slower M&A activity impacts growth strategy.
Advances: Grow Asset Management business and AUM
AUM growth supports asset management objectives.
